Trade Ideas June 19, 2026 06:51 AM

Paying Up for the Nuclear Recovery: Why Buying Cameco Around $106 Makes Sense

High multiple, but tangible catalysts and tight supply dynamics make CCJ a disciplined long trade for patient investors.

By Hana Yamamoto
Share
Twitter Reddit Facebook LinkedIn
CCJ

Cameco (CCJ) trades near $106 with a P/E approaching 98x. That multiple looks rich until you layer in accelerating global reactor builds, a rising uranium price, expanding ownership of strategic Cigar Lake reserves, and improving earnings growth. This trade idea lays out an actionable long entry at $106.50, a $135 target and a $92 stop, with a recommended hold through the next 180 trading days to let contracts and commodity strength drive earnings.

Paying Up for the Nuclear Recovery: Why Buying Cameco Around $106 Makes Sense
CCJ
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Cameco trades at ~$106.50 with a market cap near $46.7B and a trailing P/E around 98x.
  • Structural supply tightness and rising uranium prices support earnings upside and justify paying a premium for future cash flow.
  • Actionable trade: buy at $106.50, stop at $92.00, target $135.00, hold long term (180 trading days).
  • Catalysts include contract announcements, uranium price strength, and closer integration of Cigar Lake volumes.

Hook & Thesis
Cameco (CCJ) is trading at roughly $106.50 today with a market cap near $46.7 billion and a P/E close to 98x. That looks expensive on the surface, but the premium reflects a structural shift in the uranium supply/demand picture: rising reactor construction, larger long-term supply contracts, and a materially higher uranium price than the bottom of the last cycle. My thesis is simple - buying CCJ around $106.50 is a justified speculative long for investors who accept concentrated commodity exposure and a high multiple, because near-term cash flow and contract wins should compress downside risk while providing room for upside if uranium prices and contract volumes continue to normalize.

Why the market should care
Cameco is one of the purest ways to access the nuclear fuel cycle. The company operates through two main businesses: Uranium (exploration, mining and sale of uranium concentrate) and Fuel Services (refining, conversion, fuel fabrication). Beyond mining, Cameco has strategically important stakes and contractual footprints that position it to benefit from an expanding global nuclear fleet. The market cares because uranium is a tight, lumpy market; when prices move and long-term contracts are written, earnings can re-rate quickly. That dynamic is what justifies paying a high multiple today.

Key company facts and recent data

Metric Value
Current price $106.50
Market cap $46,741,189,856.79
P/E (trailing) ~98x
Shares outstanding 438,884,411.80
Float 434,470,299.48
52-week range $67.60 - $135.24
Dividend per share $0.171852 (annual)
PB ratio 9.09

Fundamental drivers that support buying a high multiple

  • Rising uranium price environment: Uranium spot prices have roughly doubled since 2021 and sat near $66/lb in early 2026, which materially improves Cameco's margin profile and cash generation when those price moves flow into contracted sales and market-priced sales.
  • Contracting and offtake wins: The company has secured large supply agreements, including a reported $1.9 billion deal with India. Longer-term contracts smooth revenue and reduce realized-price volatility versus spot-only exposure.
  • Strategic reserve and asset control: Recent transactions increase Cameco's stake in the Cigar Lake mine, consolidating its access to a tier-one deposit and improving the optionality and reliability of future volumes as demand rises.
  • Operational leverage: With a tight market, incremental uranium margin falls almost directly to the bottom line once fixed costs are covered. Cameco’s mining and fuel services scale means higher uranium prices can translate to outsized EPS growth; Q1 2026 showed an 88% year-over-year EPS increase per recent company commentary.

Technical backdrop & market behavior
From a short-term technical standpoint, the stock sits just above its 10-day SMA ($103.32) and below the 50-day SMA ($113.11), with RSI around 48 and a mildly bullish MACD histogram. Short interest is modest in absolute terms (~6.2M shares with days-to-cover around 2.16 most recently), but daily short volume spikes show active trading and episodic bearish positioning. These signals suggest the market is still digesting the recovery and that well-sized flows can move price quickly in either direction.

Valuation framing
Yes, the trailing P/E near 98x is expensive relative to typical miners and to broader energy names. But two qualitative points shift the calculus:

  • Cameco is not a generic cyclicals miner; it's a strategic supplier to a small, politically sensitive market where long-term contracting is common. That gives the company quasi-regulated earnings characteristics once contracts are in place.
  • Reported earnings have reaccelerated: recent quarterly commentary highlighted 7% revenue growth and a large EPS leap in the latest reporting period. If that trajectory continues as contracts roll, forward P/E will fall rapidly even if the stock stays flat.

So the multiple is a bet on continued earnings re-rating rather than a permanent valuation anchor. For investors buying at ~98x, the key question is whether contracts and uranium prices sustain the earnings recovery.

Catalysts (what could drive the trade)

  • Contract announcements and supply deals with utilities or sovereign buyers (expected through the next 6-12 months).
  • Uranium spot and term price strength driven by reactor build activity and inventory restocking.
  • Regulatory approvals and closing of the Cigar Lake ownership increase (transaction noted to close in Q3 2026 subject to approvals), which consolidates Cameco’s mine economics.
  • Improved quarterly reporting showing continued EPS growth and free cash flow expansion (quarterly cadence over the next three reports will be market-moving).

Trade plan - actionable and time-boxed
I recommend a long entry at $106.50. This trade is intended as a long-term directional play with tactical stop-management.

  • Entry: $106.50
  • Stop loss: $92.00 - a level that protects capital if uranium prices reverse materially or if earnings disappoint. Trigger a re-evaluation if stopped out.
  • Target: $135.00 - roughly in line with the 52-week high of $135.24 and a level that captures a sizable re-rating while leaving room to re-enter on weakness.
  • Horizon: long term (180 trading days) - hold through expected contracting announcements and at least two quarterly reports so earnings and contracts can prove the bullish case. If catalysts accelerate, scale out opportunistically toward the target.

Why 180 trading days? Uranium contracting cycles and reactor-related demand take time to translate into booked revenue and reported EPS. Expect meaningful evidence of the thesis in the next two to four quarters; 180 trading days gives the trade room to work while keeping position size finite.

Position sizing & execution notes
Treat this as a high-conviction but volatile position. Size it so that a stop-triggered loss at $92 would be acceptable to your portfolio risk tolerance. Consider scaling in halves: half at $106.50 and the remainder on weakness toward $100 or on confirmation of a new contract.

Risks and counterarguments

  • Commodity price reversal - Uranium prices are the single biggest driver. If spot and term prices fall materially, Cameco’s earnings and the stock multiple can contract quickly. This is the primary downside scenario.
  • Execution and operational risk - Mining is capital intensive and subject to delays, cost overruns, and regulatory interruptions. Any material operational hiccup at flagship operations like Cigar Lake would dent the thesis.
  • Policy or public sentiment swings - Nuclear power remains politically sensitive. Changes in policy, permitting, or high-profile accidents (even elsewhere) could slow new builds and reduce demand for uranium.
  • Valuation resets - Paying ~98x assumes earnings will improve materially. If EPS growth stalls or disappoints, the stock could re-rate sharply lower because expectations are elevated.
  • Concentration of customers and geopolitical risk - Large offtakes and country-level deals introduce counterparty and geopolitical concentration. Changes in trade patterns or sanctions regimes could affect volumes and pricing.
Counterargument: The most persuasive bearish case is that the market has already priced in a best-case uranium recovery and that downstream reactor deployments, while growing, will take longer to materially boost Cameco’s contracted volumes and realized prices. If that patience is misplaced, a high multiple becomes a valuation trap and shares could fall 20-40% before stabilizing.

What would change my mind
I would reduce conviction or close the position if any of the following happen: (1) a sustained slide below $92 on high volume, (2) repeated quarterly misses on revenue or EPS indicating that contract wins are not translating to bookings, or (3) sudden, material setbacks to reactor construction programs in key markets that reduce long-term uranium demand. Conversely, I would add to the position if Cameco announces multiple, long-dated offtake contracts or if spot and term uranium prices move materially higher from current levels.

Conclusion
Buying Cameco at $106.50 is not a passive dividend play or a low-multiple defensive bet. It is a focused, catalytic trade that bets on continued uranium price strength, successful contracting, and improved EPS momentum. The company’s strategic asset base and recent transactions (including increasing its stake in Cigar Lake and large supply agreements) give the trade real optionality. Use disciplined sizing, a clear stop at $92, and a 180-trading-day time box to let the fundamentals and contracting cadence play out.

Bottom line: If you’re comfortable with commodity-driven cyclicality and the elevated valuation, CCJ at $106.50 for a long-term hold to $135 is a coherent trade. If you need low volatility or near-term dividends, this isn’t the play.

Risks

  • Uranium price reversal that materially compresses margins and realized revenue.
  • Operational setbacks or production disruptions at key mines such as Cigar Lake.
  • Policy and regulatory shifts that slow reactor builds or constrain nuclear fuel purchasing.
  • Valuation compression if earnings growth disappoints after a high multiple has been priced in.

More from Trade Ideas

Buy DHX on Cash-Flow Strength: Cheap, Cash-Generating, and Undervalued Jun 19, 2026 Cognizant at a Crossroads: Oversold, Cheap, and Worth a Tactical Long Jun 19, 2026 Merlin: Technical Win Socializes Upside — Buy on a Confirming De-Risk Event Jun 19, 2026 Xometry After the Rally - Why I'm Still Buying and Where I Draw the Line Jun 19, 2026 SmartRent at the Bargain Bin: Tactical Long After a Downgrade Jun 19, 2026